Making the Diagnosis: ECG and Genetics in SQT2
At a Glance
Short QT Syndrome Type 2 is diagnosed by combining the heart-rate-corrected QT interval on an ECG with clues such as fainting or a family history of sudden cardiac events at a young age. A pathogenic KCNQ1 result may support diagnosis, while a variant of uncertain significance is not definitive.
Confirming a diagnosis of Short QT Syndrome Type 2 (SQT2) is more complex than simply looking at one heart tracing. Because the heart’s electrical “recharge” time (the QT interval) naturally speeds up when your heart beats faster, doctors must use specific formulas and criteria to determine if your heart’s reset is truly shorter than it should be [1]. This page explains the diagnostic “math” and the essential technical terms you may see on your medical reports.
The Diagnostic Thresholds: How “Short” is Short?
A diagnosis is rarely based on a single number. Instead, international guidelines, such as those from the 2022 European Society of Cardiology (ESC), use a combination of measurements and clinical history [2][3].
Current consensus typically classifies a diagnosis in two ways:
- Definitive Diagnosis: A heart rate-corrected QT interval (QTc) that is ≤ 320 milliseconds (ms) [2][3].
- Supported Diagnosis: A QTc between 330 and 360 ms, but only if you also have “supportive features,” such as a confirmed pathogenic genetic mutation, a history of fainting (syncope), or a family history of sudden cardiac events at a young age [3][4]. It is important to note that a pathogenic variant is supportive, not mandatory.
The Importance of Correction Formulas
Because your heart rate changes throughout the day, doctors use formulas to calculate what your QT interval would be if your heart were beating at exactly 60 beats per minute. This is called the QTc (corrected QT) [1].
- Bazett vs. Fridericia: These are two common formulas. The Bazett formula generally over-corrects at fast heart rates (making the QTc appear falsely long), and under-corrects at slow heart rates (which can make the QTc appear falsely short) [5]. Because SQT2 can involve slow heart rates, this is clinically important. The Fridericia formula is often considered more stable [6].
- Manual Measurement: No correction formula is perfect at extreme rates; borderline values require appropriate manual measurement and specialist interpretation [1].
- Atrial Fibrillation (AF): If you are in AF, your heart rate is irregular, which makes it very difficult for computer software to calculate an accurate QTc. In these cases, a specialist must manually average the QT interval over several different beats to get an accurate reading [7].
Decoding Your Diagnostic Report
You may encounter these five technical terms in your cardiology or genetics reports:
- QTc (Corrected QT Interval): The primary measurement of your heart’s electrical reset time, adjusted for your heart rate [1].
- T-wave Morphology: This describes the shape of the T-wave. In SQTS, T-waves are often described as tall, peaked, and narrow-based [8][4].
- Early Repolarization: A pattern of small “notches” at the start of the reset phase. This is much more common in people with SQTS than in the general population [6].
- Pathogenic / Likely Pathogenic Variant: A genetic change that laboratory grading considers strongly supported as disease-causing. In SQT2, this is a variant in the KCNQ1 gene [9].
- Variant of Uncertain Significance (VUS): A genetic change where the scientific community does not yet have enough evidence to say if it causes disease or is just a normal human variation [10]. A VUS should not be used to make definitive treatment or family-screening decisions.
The Role of Exercise Testing
An exercise stress test can provide additional clues in suspected SQTS. Normally, as your heart rate increases during exercise, your QT interval should shorten in a predictable way. In some people with SQTS, this adaptation is often “blunted,” meaning the QT interval does not change as much as expected as the heart rate rises [11]. While exercise testing may help in selected borderline cases, it is not required or independently diagnostic for every patient, and the interpretation is specialized [11].
Completeness Checklist for Your Records
A high-quality diagnostic report for SQT2 should include several specific data points. If any of these are missing, you should ask your medical team to provide an addendum or a more detailed summary:
- [ ] Precise QTc Value: The exact measurement in milliseconds (e.g., 315 ms).
- [ ] Correction Formula Used: A note stating if they used Bazett, Fridericia, or another method.
- [ ] Manual Verification: Confirmation that a human specialist (electrophysiologist) manually reviewed the computer’s measurement.
- [ ] Genetic Classification: If a mutation was found, the specific gene (KCNQ1) and whether it was labeled Pathogenic, Likely Pathogenic, or a VUS.
- [ ] Supporting Clinical Features: A clear list of any symptoms (like fainting) or family history used to support the diagnosis.
Common questions in this guide
What QTc level is considered diagnostic for SQT2?
Why can Bazett and Fridericia produce different QTc results?
What does a KCNQ1 result mean on SQT2 genetic testing?
Why might my ECG need a manual QT measurement during atrial fibrillation?
Is an exercise test required to diagnose SQT2?
What should my SQT2 diagnostic report include?
Get notified when new evidence is published on short QT syndrome type 2.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Impact of QTc formulae in the prevalence of short corrected QT interval and impact on probability and diagnosis of short QT syndrome.
Providência R, Karim N, Srinivasan N, et al.
Heart (British Cardiac Society) 2018; (104(6)):502-508 doi:10.1136/heartjnl-2017-311673.
PMID: 28954836 - 2
Familial Short QT Syndrome: Phenotypic Variability and Challenges in Risk Stratification.
Bouzón P, Alen A, Salgado M, et al.
Journal of clinical medicine 2026; (15(9)) doi:10.3390/jcm15093461.
PMID: 42123196 - 3
Preclinical short QT syndrome models: studying the phenotype and drug-screening.
Fan X, Yang G, Kowitz J, et al.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2022; (24(3)):481-493 doi:10.1093/europace/euab214.
PMID: 34516623 - 4
Long-term prognosis of short QT interval in Korean patients: a multicenter retrospective cohort study.
Kim DY, Uhm JS, Kim M, et al.
BMC cardiovascular disorders 2021; (21(1)):17 doi:10.1186/s12872-020-01824-3.
PMID: 33407155 - 5
Relevance of accurate QT correction in the assessment of long QT syndrome.
Kanniainen M, Pukkila T, Aalto-Setälä K, Räsänen E
Journal of electrocardiology 2024; (87()):153790 doi:10.1016/j.jelectrocard.2024.153790.
PMID: 39232409 - 6
Novel electrocardiographic criteria for short QT syndrome in children and adolescents.
Suzuki H, Horie M, Ozawa J, et al.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2021; (23(12)):2029-2038 doi:10.1093/europace/euab097.
PMID: 34179980 - 7
Short QT Syndrome Masquerading as Lone Atrial Fibrillation: Hidden in Plain Sight.
Yoo TK, Trujillo-Arvizu L, Kaufman C, et al.
JACC. Case reports 2026; (31(30)):108675 doi:10.1016/j.jaccas.2026.108675.
PMID: 42530204 - 8
Short QT syndrome: The current evidences of diagnosis and management.
Dewi IP, Dharmadjati BB
Journal of arrhythmia 2020; (36(6)):962-966 doi:10.1002/joa3.12439.
PMID: 33335610 - 9
Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death.
Walsh R, Adler A, Amin AS, et al.
European heart journal 2022; (43(15)):1500-1510 doi:10.1093/eurheartj/ehab687.
PMID: 34557911 - 10
Interpreting the actionable clinical role of rare variants associated with short QT syndrome.
Martínez-Barrios E, Greco A, Cruzalegui J, et al.
Human genetics 2024; (143(12)):1499-1508 doi:10.1007/s00439-024-02713-x.
PMID: 39503779 - 11
Usefulness of exercise test in the diagnosis of short QT syndrome.
Giustetto C, Scrocco C, Schimpf R, et al.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2015; (17(4)):628-34 doi:10.1093/europace/euu351.
PMID: 25833882
This page explains how ECG measurements and genetic results are used to evaluate Short QT Syndrome Type 2 for informational purposes only and does not constitute medical advice. A cardiologist or electrophysiologist should interpret your individual report.